December 19, 2016
Personal Genome Diagnostics Launches CancerSELECT™ 125 Test for Pan-Cancer Tumor Profiling –Identifies Tumor-Specific, Clinically Actionable Genetic Alterations to Inform Treatment Decisions with Unparalleled Accuracy
BALTIMORE / PRNewswire/ — Personal Genome Diagnostics Inc. (PGDx), a leading provider of advanced cancer genome testing products and services, today announced the launch of its CancerSELECT™ 125 test for pan-cancer … Continued